BME:ALMPharmaceuticals
Almirall (BME:ALM): Reworked Debt Structure Prompts Fresh Look at Valuation After New 2031 Bond Issue
Almirall (BME:ALM) just reshaped its balance sheet, planning to redeem its €300 million 2.125% notes due 2026 while issuing €250 million in 3.75% senior unsecured notes maturing 2031, representing a meaningful capital structure refresh.
See our latest analysis for Almirall.
The new bond issue and planned redemption come as Almirall’s €12.84 share price rides strong momentum, with a 90 day share price return of 14.03% and a robust 1 year total shareholder return of 56.95% signaling that...